Search Results 1021-1030 of 4595 for 留痕官网咨询邮箱：lgooxc@hotmail.com
Email: intl.mcr@mayo.edu. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions ...
2. To examine the safety and efficacy of initial alemtuzumab treatment in this study for patients who received Rebif® (interferon beta-1a) as their study ...
This study will validate a bowel diary to be used for a forthcoming study comparing effectiveness of biofeedback, sacral nerve stimulation, and injectable ...
This is a single arm, open-label, multi-center, phase 1/2 study, to determine the safety and efficacy of KTE-X19, an autologous anti-CD19 chimeric antigen ...
The purpose of this study is to investigate disease causing and other organisms which athletes may be exposed to while participating in the Summer Olympic Games ...
difficile infection irritable bowel syndrome. We will study patient characteristics and study stool samples to investigate if bile acid composition, microbiome ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.